A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

More information: Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis, The Lancet Child & Adolescent Health (2025 ...

RSV is a leading cause of serious respiratory illness in young children particularly in the first six months of life, responsible for millions of hospitalisations of children around the world ...

Experts attributed those years to a rebound in RSV and flu infections after two ... a lab-made antibody shot for infants that helps the immune system fight off the virus, and the other was giving ...

RSV-induced changes included a robust innate immune response and the activation of genes associated with interferon signaling. These findings demonstrate the organoids' ability to replicate the ...